Repair Biotechnologies Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$11.4M
- Investors
-
14
Repair Biotechnologies General Information
Description
Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. The company's cholesterol-degrading platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemia, and other conditions in which excess or modified cholesterol drives pathology, enabling healthcare providers to rapidly and dramatically reduce atherosclerotic plaque in arteries, the cause of stroke, heart attack, and other cardiovascular diseases.
Contact Information
Website
www.repairbiotechnologies.comCorporate Office
- 841 East Fayette Street
- Syracuse, NY 13210
- United States
Corporate Office
- 841 East Fayette Street
- Syracuse, NY 13210
- United States
Repair Biotechnologies Timeline
Repair Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 25-Nov-2025 | $11.4M | Completed | Pre-Clinical Trials | ||
| 3. Seed Round | 21-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-Sep-2020 | $2.85M | $2.88M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 10-Aug-2018 | $25K | $25K | Completed | Pre-Clinical Trials |
Repair Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed B-3 | ||||||||
| Seed B-2 | ||||||||
| Seed B-1 | ||||||||
| Seed B | ||||||||
| Seed A-6 | ||||||||
| Seed A-5 | ||||||||
| Seed A-4 | ||||||||
| Seed A-3 | ||||||||
| Seed A-2 | 109,365 | $0.000010 | $2.51 | $2.51 | 1x | $2.51 | 0.41% | |
| Seed A-1 | 170,125 | $0.000010 | $0.29 | $0.29 | 1x | $0.29 | 0.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Repair Biotechnologies Patents
Repair Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025242780-A1 | Atherosclerotic plaque reduction treatments and compositions | Pending | 25-Mar-2024 | ||
| WO-2025207597-A1 | Atherosclerotic plaque reduction treatments and compositions | Pending | 25-Mar-2024 | ||
| JP-2024501867-A | Compositions for the treatment, prophylactic treatment and use thereof of hepatocellular carcinoma | Pending | 30-Dec-2020 | ||
| AU-2021416182-A1 | Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith | Pending | 30-Dec-2020 | ||
| AU-2021416182-A9 | Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith | Pending | 30-Dec-2020 | A61K38/443 |
Repair Biotechnologies Signals
Repair Biotechnologies Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LongGame Ventures | Venture Capital | Minority | ||
| 100 Plus Capital | Impact Investing | Minority | ||
| Bioverge | Venture Capital | Minority | ||
| Healthspan Capital | Venture Capital | Minority | ||
| quadraScope Ventures | Venture Capital | Minority |
Repair Biotechnologies FAQs
-
When was Repair Biotechnologies founded?
Repair Biotechnologies was founded in 2018.
-
Where is Repair Biotechnologies headquartered?
Repair Biotechnologies is headquartered in Syracuse, NY.
-
What is the size of Repair Biotechnologies?
Repair Biotechnologies has 10 total employees.
-
What industry is Repair Biotechnologies in?
Repair Biotechnologies’s primary industry is Drug Discovery.
-
Is Repair Biotechnologies a private or public company?
Repair Biotechnologies is a Private company.
-
What is the current valuation of Repair Biotechnologies?
The current valuation of Repair Biotechnologies is .
-
What is Repair Biotechnologies’s current revenue?
The current revenue for Repair Biotechnologies is .
-
How much funding has Repair Biotechnologies raised over time?
Repair Biotechnologies has raised $22.9M.
-
Who are Repair Biotechnologies’s investors?
LongGame Ventures, 100 Plus Capital, Bioverge, Healthspan Capital, and quadraScope Ventures are 5 of 14 investors who have invested in Repair Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process